Myocarditis Risk Remains Rare After Third mRNA Vaccine Dose | tctmd.com
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
Myocarditis, pericarditis incidence low across 10 million doses of mRNA COVID-19 vaccines
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022 | MMWR
ESC 365 - Myocardial Inflammation/Myocarditis After COVID-19 mRNA Booster Vaccination.
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization | NEJM
Myocarditis With COVID-19 mRNA Vaccines | Circulation
Myocarditis: A Rare Occurrence Following COVID-19 Vaccination | University of Utah Health
News Flash • Clinician Update: Myocarditis-Pericarditis foll
Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature | BMJ Open
RACGP - TGA releases updated COVID booster safety data
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents | NEJM
COVID-19 infection more likely than vaccines to cause rare cardiovascular complications — Nuffield Department of Primary Care Health Sciences, University of Oxford
Israel reports very few myocarditis cases among 12-15 year olds after booster | Reuters
Israel reports very few myocarditis cases after Pfizer boosters | Reuters
Myocarditis With COVID-19 mRNA Vaccines | Circulation
Men aged 12-29 can switch to Pfizer vaccine due to risk of heart inflammation linked to Moderna | NHK WORLD-JAPAN News
Systematic review and meta-analysis of myocarditis and pericarditis in adolescents following COVID-19 BNT162b2 vaccination | npj Vaccines
Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines | Journal of the American College of Cardiology
Myocarditis After BNT162b2 COVID-19 Third Booster Vaccine in Israel | Circulation
Heart risks, data gaps fuel debate over COVID-19 boosters for young people | Science | AAAS
Myocarditis and pericarditis - rare adverse reactions to Comirnaty (Pfizer COVID-19 vaccine)
Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC ...
Myocarditis and pericarditis following COVID-19 vaccines - The Melbourne Vaccine Education Centre (MVEC)
Myocarditis Associated With COVID-19 Booster Vaccination | Circulation: Cardiovascular Imaging
CDC Extends COVID-19 Boosters to Adolescents, but Myocarditis Is Top of Mind | tctmd.com
